Council for Tobacco Research
Joint Committee on Tobacco and Health [St]
Abstract
MAR
Fields
- Depository Date
- 25 Sep 1995
- Request
- 118
- Master ID
- Ctrmn00014501-5129
Related Documents:- CTRMN014501-4661 Deposition of Sheldon C. Sommers [Deposition of Sommers in the Matter of Cipollone]
- CTRMN014662-4664 US District Court for the District of New Jersey Honorable H. Lee Sarokin - Docket No. 83-2864sa Civil Action - Notice to Take Oral Deposition of Sheldon C. Sommers, M.D. Antonio Cipollone, Individually and As Executor of the Estate of Rose D. Cipollone, Plaintiff, Vs. Ligget Group Inc., A Delaware Corporation; Philip Morris Incorporated, A Virginia Corporation; and Lowe's Theatres Inc., A New York Corporation, Defendants [Notice to Produce Documents Regarding Contracts with the Tobacco Institute and Dr. Oscar Auerbach]
- CTRMN014665-4666 Cipollone V. Ligget, Et Al. Our File No. 03356-113151 [Request to Present at Interview by Counsel]
- CTRMN014667-4667 Cipollone V. Liggett [Request to Take Deposition Disagreement with Tone or Content of Statements]
- CTRMN014668-4704 Thomas Hoyt Council Tobacco Resesarch 110-E-59st [Regarding Invitation to Review Experimental Material and Permit Expert to See Slides and Protocols]
- CTRMN014705-4715 Hearings Before the Consumer Subcommittee of the Committee on Commerce United States Senate Ninety-Second Congress Second Session on S. 1454 - to Amend the Federal Cigarette Labeling and Advertising Act to Require the Federal Trade Commission to Establish Acceptable Levels of Tar and Nicotine Content of Cigarettes February 1, 3, and 10, 1972 Serial No. 92-82 [Regarding Public Access to Information About Tar and Nicotine]
- CTRMN014716-4725 Hearings Before the Consumer Subcommittee of the Committee on Commerce United States Senate Ninety-Second Congress Second Session on S. 1454 - to Amend the Federal Cigarette Labeling and Advertising Act to Require the Federal Trade Commission to Establish Acceptable Levels of Tar and Nicotine Content of Cigarettes February 1, 3, and 10, 1972 Serial No. 92-82 [Money Funded by Tobacco Companies Expended for Research Grants and Contracts to Study Relevance of Proposals Received to Smoking and Health Problems]
- CTRMN014726-4762 Hearings Before the Committee on Interstate and Foreign Commerce House of Representatives Ninety-First Congress First Session on H.R. 643 - A Bill to Amend the Federal Cigarette Labeling and Advertising Act with Respect to the Labeling of Packages of Cigarettes and for Other Purposes (and Similar Bills) H.R. 1237 - A Bill to Direct the Federal Communications Commission to Establish Regulations Prohibiting Certain Broadcasting of Advertising of Cigarettes (and Similar Bills) H.R. 3055 - A Bill to Strengthen the Federal Cigarette Labeling and Advertising Act (and Similar Bills) H.R. 6543 - A Bill to Extend Public Health Protection with Respect to Cigarette Smoking and for Other Purposes (and Similar Bills) April 15, 16, 17, 18, 21, 22, 23, 24, 25, 28, 29, 30, and May 1 Serial No. 91-12 [Hearings Regarding A Program to Sharpen the Objectives of Supported Research of Tobacco and Health]
- CTRMN014763-4763 [Correspondence Containing Information on A Booklet Explaining Insurance and Retirement Plans for Employees of the Council for Tobacco Research]
- CTRMN014764-4778 Employment Agreement Between the Council for Tobacco Research - U.S.A., Inc. And Sheldon C. Sommers, M.D. [Mutual Covenants on Employment, Job Position, Terms, and Duties]
- CTRMN014779-4826 Hearings Before the Subcommittee on Health of the Committee on Labor and Public Welfare United States Senate Niety-Fourth Congress Second Session on S. 2902 - to Amend Title V of the Public Health Services Act to Establish A National Health Research and Development Advisory Commission, and for Other Purposes February 19, March 24, and May 27, 1976 [Hearings Regarding Most Recent Scientific Data on the Higher Rate of Death of Smokers Compared to Nonsmokers]
- CTRMN014827-4893 Deposition of Dr. Sheldon Sommers [Deposition of Sommers in the Matter of Rogers]
- CTRMN014894-4917 [St]
- CTRMN014918-4921 Statement of Dr. Sheldon C. Sommers [St]
- CTRMN014922-4922 Cigaret Blame for Cancer Is Questioned [Three Doctors Question Whether Smoking Causes Lung Cancer. Investigators Validity Challenged.]
- CTRMN014923-4926 [Insufficient Scientific Evidence to Prove Smoking Causes Diseases]
- CTRMN014927-4930 Statement of Sheldon C. Sommers, M.D. Before the Consumer Subcommittee of the U.S. Senate Interstate Commerce Committee [Regarding Research on Possibility of Tobacco Causing Cancer]
- CTRMN014931-4931 Scientific Advisory Board Members 1954-1978 [Listing of Accepted and Resigned Individuals of Scientific Advisory Board]
- CTRMN014932-4932 [New Scientific Director Assists Advice in Research Planning in the Pulmonary Disease Field]
- CTRMN014933-4934 [Successor for Scientific Director and Other Staff Positions in Short Supply]
- CTRMN014935-4935 [List of Names]
- CTRMN014936-4938 [Confidential Run-Down of What Occurred with Homburger at Federation Meeting in Atlantic City. Paper on Censorship]
- CTRMN014939-4941 [Memo Regarding the Enclosure of A Letter to Editor]
- CTRMN014942-4943 [Correspondence Regarding J.A.M.A. Not Publishing Study About Squamous Lung Carcinoma]
- CTRMN014944-4945 [Correspondence Regarding Wk's Letter. William Kleepfer Letter to the Editor.]
- CTRMN014946-4947 ["Follow-Up to Publication in Archives of the "Smoking Dog" Reports. Summary of Recommendations Arising From the Meeting."]
- CTRMN014948-4950 [Observations Concerning Articles by Drs. Hammond, Auerbach, Messrs. Kirman and Garfinkel, Published in Arch. Environ. Health]
- CTRMN014951-4952 [Article Regarding Experimental Design, Mortality, and Lung Parenchyma]
- CTRMN014953-4955 Chronic Smoke Inhalation Experiments [Long Term Experiments Involving Cigarettes and Smoke Inhalation on Larger Animals, Rather Then the More Feasible Mice, Rats, and Hamsters.]
- CTRMN014956-4957 Auerbach-Hammond Why the Present Proposal Is Not Worth Carrying Out [Procedures in Conducting Tests of Smoke on Lungs]
- CTRMN014958-4960 Why the Proposed Study Cannot Produce Meaningful Results [Tests of Smoke Intake of the Lungs and Overall Pulmonary System Are Inaccurate with the Normal Consumption of Smoke in Humans]
- CTRMN014961-4961 No. 826 - Dawber [Framingham Material Occupies A Key Position in Reference to Factors Related to Coronary Disease]
- CTRMN014962-4963 ["Memo Regarding Enclosed Article]
- CTRMN014964-4964 [Correspondence Containing Four Short Essays on the Present Status of Various Fields in Smoking and Health]
- CTRMN014965-4965 [""Highly Critical" Letters to Appear in American Druggist in Defense of Cigarette Smoking"]
- CTRMN014966-4966 [American Druggist Magazine Has Received A Number of Highly Critical Letters Regarding A Dr. Sommers Article]
- CTRMN014967-4969 in Defense of Cigarettes [Research Regarding the Smoking of Tobacco May Not Be A Serious Cause of Disease As Previously Thought]
- CTRMN014980-4990 Tobacco and Health Research Some Proposed Studies [Study for Cancers, Cardiovascular Disease, Chronic Lung Disease, and Other Related Physical Ailments.]
- CTRMN014991-5129 Deposition of Sheldon C. Sommers [Deposition of Sommers in the Matter of Cipollone]
- Box
- 007
- Type
- MINUTES
- UCSF Legacy ID
- dfs30a00
Document Images
H KO0894G97 ~~
Revised
JOIMf COA~QITTEE ON TOBACCO AND KEALTH
San Francisco Hilton Thursday
San Francisco, Calif. June 20, 1968
Present (See attached list)
Purpose of the MeetinR
Dr. Endicott opened the meeting at 9:15 a.m. by stating his understanding
of its purpose:
"Recently, otticials of the Department of Health, Education and
Welfare met with executives of the tobacco industry to discuss
areas of mutual interest. Among other things,'tbe group agreed
that there are gaps in our knowledge about tobacco and health.
~ It was decided that a group of esperts be asked to identiiy these
gaps and to recommead appropriate action including work to be
done, estimated costs, and priorities.
"It was further decided that the Department should invite repre-
sentatives of the Committee for Research on Tobacco and Sealth
of the American Yedical Association Education and Research
Foundation, and the Scientific Advisory Board of the Council for
Tobacco Research to meet with representatives of the National
InstitutM of Health to plan the Croup effort. It is hoped that
such a meeting will develop a cooperative effort of industry and
government to fill the knowledge gaps."
Senator Clements read the tollowins statement:
"Doctor Zndicott, we concur in your statemsnt and join in your
hope for a fruitful and cooperative eftort.
"we agree with your observation that there are gaps in our
knowledge about tobacco and health, and recognize that our
initial goal in this continuing dialogue is to identify these
many gaps. We must seek agreement on what can and should be
done, and follow through on recossiendations made in mutual
good faith.
THIS DOCUMENT SUBJECT TO
CONFIDEHTIALITY AGREEMENT.
'~~
CT' HN 0 149-

~ ~
~;C
~ ^
C
~3
Joint Committee ~ ,
. ~r ~
~.8
t~
)
on Tobacco and Health - 2 -
"Representatives of cigarette companies are here today. As
you well know, these companies have for years funded independent
research grants administered by the Scientific Advisory Board
of the Council for Tobacco Research -- U.S.A., or by the
Education and Research Foundation of the American Medical
Association. The interest of these companies in scientific
areas pertaining to tobacco and health is a continuing one.
°We genuinely hope that this meeting will be the beginning of
meaningtul cooperation to find the needed answers."
In reaponse to Dr. Seevers' question, Dr. Endicott elaborated on his
statement. It is his personal hope that a continuing liaison group
will be formed to provide communication of the research supported by the
different groups and possibly to stimulate joint planning for specific
projects that might be sponsored. 8owrver, the present meeting was
called in response to conversations held in the Secretary's office during
which an industry spokesman proposed that a joint government-industry .
program should include facing the problem squarely, attempting to
determine what needs to be done to resolve it, and then getting on with it.
The Secretary indicated that he would welcome a specific proposal of
the work to be undertaken, the priorities, and the cost in order to
i determine a budget for the government's part of the program which he
might propose to the Congress. Dr. Endicott thought it implicit that
a subsequent meeting between Department and industry representatives
would be held after a scientific group had assessed the state of the
art and had recommended which part each group would undertake and how
they might work together.
Gaps in EnowledRo
Dr. Baker questioned the meanins of the word "gaps"-he understood it
to refer to establishizg associations between certain conditions in
man and smoking, as well as modifying cigarettes. 8o asked Drs. Little
and Seevers how their respective committees had approached this problem
and whether they sought applications or funded the best of the proposals
submitted to them.
Council for Tobacco Research: Dr. Little stated that as the Scientific
Advisory Board had evolved and accusulated enough information to define
its targets, it had begun to initiate and to seek projects on this tar-
get. At present, a sub-comtiittee of thres members is reviewing previous
epidesiolo.*ic studies with respect to the specific probla of exposure
to whole tobacco smoke and measurement of inhalation, working towardr
YHIS DOCUMENT SUBJECT TO
CONFIDENTIALITY AGREEMENT.
CTR HN 014971

Joint Committee
on Tobacco and Health
n r~
HKr~.
- 3 -
i
development of an animal model as well as experimental analyses of results.
Comaittee for Research on Tobacco and Health: Dr. Seevers indicated his
committee exchanges information about Frantees with the Council to pre-
vent duplication of support in this area. He stressed the need to
recognize that there are lnrQe and small research gaps. Although the
AblA-ERF Committee has supported a few lung cancer projects, most have
been in the areas of respiratory and cardiovascular diseases where it
could find Erantees who had the knowledQe to attack a small piece of
the problem. The Committee considers any proposal submitted to i't but
has hatd a certain amount of success in soliciting interest in the prob-
lem of smoking and health among investigators with ongoing studies in
such fields as emphysema and contributing enouHh.additional funds ao
they can include tobacco in the program. Dr. Seevers pointed out that
the Committee has been confronted by some proposals which are beyond
its financial capabilities as an individual granting aSency, and
suQaested this group consider recommending support of such projects on
a cooperative baais.
Nhtional Institutes of Health: Dr. Endicott replied that NIH had pre-
cedents for providing partial oupport of a particular study. Over the
years, NIH has received a rather limited number of proposals that are
riHht on target in this area, although many have had tangential relation-
ships. ships. Their most effeetive device for obtaining specific answers has
been the negotiated contract with the person selected as beat qualified
to solve the problem.
Establishment cS Priorit:Rs
To avoid any possible confusion, Dr. Endicott listed four areas identi-
fied for intensive research by the Task Force on Lung Cancer which was
established last spsing at President Johnson's request: (1) clinical
management of the disease; (2) long-range fundamental approach to assess
susceptibility and resistance to determine if there is any practical
means of enhancing resistance or idenYifyins susceptible individuals
and taking appropriate action; (3) industrial or occupaticnal hazards
including atmospLerio pollution; and (4) exploration of the possibility
of reducing the hazards of the cigarette.
He felt that the present meeting was concerned with the broad problem
of the biological effects of tobacco and tobacco products. However,
since the Task Force has a group which will report in early October on
bioassay and its extrapolation to effects in man, he proposed that the
Joint Cosnittee on Tobacco and Health incorporate their findings in its
own proposal to avoid repetition.
THIS DOCUMENT SUBJECT TO
CONFIDENTIALITY AGREEMENT.
~, ! t'~r 1 ~ ~ ~ ti..~ .t `' ~ t` ~ 2

J oint Committe
on Tobacco and Health
- 4 -
Dr. Little noted that the Scientific Advisory Board has been concerned
primarily with various factors of diseases in which tobacco is implicated
rather than tobacco as such. Because of this and the members' great
individual differences and strengths, he advocated proceeding surely and
slowly to determine these narrower fields of interest and then face the
problem of priorities. Also, priorities will change while they are
under consideration. He felt differences in emphasis would emerge and
each group should have the right to its own working hypothesis without
criticism from cthers.
According to Dr. Jacobson, the problem of determining priorities and,
secondly, the amount of money to be spent and how to accomplish them,
will prove more difficult than outlining the areas that require work.
Their experience suggests this will demand a great deal of staff work,
but the groups represented include the necessary talent and expertise
to attack the problem of priorities in several areas. He doubted it would
take a long time to produce such an outline, although he agreed it may -
not be possible to prepare a budget by August.
Dr. Bing noted that this committee should be aware that individual
research is the foundation of its effort and no amount of direction will
guarantee a solution. Dr. Bickam agreed, pointing out that this
/ research has long-range applications to general problems of buman disease.
He recognized the value of cooperative planning but emphasized the need
for a continuing supply of ideas and investigators. Dr. Endicott assured
the graup that the proposed action programs would not interfere with
or interrupt support of the individual investigator who applies for funds.
Procedure
Two possible approaches have been submitted by NCI staff: that the Joint
Committee sponsor one or more scientific meetings at which invited
scientists would review and discuss the evidence and then set up a smaller
committee to digest their conclusions and draft a document for consideration;
or, that a working group consider the different areas of the problem and
address themselves to this task.
Dr. Endicott said he had no particular brief for either alternative. He
agreed with Dr. Little's notion of the constantly changing scientific
picture, but pointed out the time element in terms of submitting a
budget. It is unlikely this group could reach a consensus on a plan for
the Secretary's consideration by August, so he would prefer to take
additional time and submit a supplementary proposal.
THIS OOCUMEiV i SUtt1ECT i0
CONFJDENTIALITY AGREEMEIyT,
,
CTR_ HN 0149-73

~ ~
111 1, U
Joint Committee
on Tobacco and Health - 5-
Desigcation of Sub-Committee: It was agreed that the most effective plan
would be to appoint a working sub-committee composed of representatives
from all the organizations concerned to prepare a program for the consid-
eration and criticism of the larger group. The following were selected to.
serve on this Sub-Caasmittee:
National Institutes of Health
Carl G. Baker, Y.D.
Associate Director for Program, NCI
Paul Kotin, M.D,
Director, Div. of Environmental Health Sciences
Ian A. Mitchell, M.D.
Assistant Director, NCl
Scientific Advisory Board
Council for Tobacco Research
Leon O. Jacobson, M.D.
Dean, University of Chicago School of Medicine
/
Clayton 0. Loosli, M.D., Ph.D.
Hastings Professor of !ledicine and Pathology
University of Southern California School of Medicine
Sheldon C. Sommera, ILD.
Profeisor of Pathology, Columbia University
College of Physicians and Surgeons
Committee for Research on Tobacco and Health
AMA Education and Research Foundation
Richard J, Bins, M.D.
Professor and Chairman, Dept. of Medicine
Nayaw State University 8chool of Medicine
John B. Hickas, 1t.D.
Professor and Chairman, Dept. of Medicine
Indiana University School of Eledicine
Paul S. Larson, Ph.D.
Professor and Chairman, Dept, of Pharmacology
Medical College of Virginia
Role of Industry Scientists: Dr. Jacobson recamsended that the Sub-Committee
consult with the technical people in the tobacco industry. In the dis-
cuasion, the representatives of the various tobacco companies
THIS DOCUMENT SUBJECT TO
CONFIDENTIALITY AGREEMENT.
~ t t ~'' 0 1'~ 9 "t`~'~
CT:

P -,
r/ V
Joint Committee
on Tobacco and Health
- 6 -
expressed their willingness to furnish any information that mieht be
helpful but noted that these men are primarily physical scientists and
comaorcially oriented. It wao concluded that the Sub-Commlttee would
consist of the above representatives from NIH, the Council for Tobacco
Research, and the Committee for Research on Tobacco and Health, and that
this group should feel free to requast information from or invite
participation of e.tperts associated with any of the tobacco companies.
/
In oummary, Dr. Endicott stated that the mission of the newly constituted
Sub-Cammittee is to plan how it will prepare an assessment of the state
of the art in the field of tobacco and health; an identification of the
important gaps in the different areas of knowledge and recamomendations
on how to fill in these gaps through scientific investigation as well
as speu:fyin8 priorities. A second consideration is determining which
areas are ready for exploitation in terms of the availability of the
seiantific tools. It waa his understanding that the Sub-Carmitte, will'
decide wbethir to develop a statement themselves, draw in consultants,
or hold additional meetings. When this group is in a position to
communicate with the Joint Committee, he will contact,Senator Clements
to discuss the next step as agreed at the meeting in the Secretary's
office.
Dr. Jacobson added that the purpose should include establishing liaison
between these three groups for essentially the same objectives and to
correlate their work. Rather than making specific assiRaments to each
group, he understood that the general areas of work would be outlined
and that such liaison would prove beneficial to all in terms of reaearch
expenditures. Dr. Eadicott agreed all three groups certainly would
continue to edJoy freedom of action and there is no suggestion of
compulsion to accept the forthcoming recommendations.
'4 y
On behalf of the industryi 1lr. Rams emphasized that the Council for
Tobacco Research and the Co®ittee for Research on Tobacco and Health
consist of outstandias scientists who view this problem impartially
and have a great deal to eoatribute. He assured thes that the present
meeting in no way negated their importanee as groups or as individual
scientists, and that the industry needs as much expertise, ability and
independenoe of thought as it ever has. Their functions are essentially
as they always have been. The purpose of these discussions is an attempt
to encourage additional cooperation and possibly to find answer* faster
by the pooling of abilities.
The m"tins adjourned at 10tS0 a.m, to permit the Sub-Committee to meet
before the iarler group reconvened at 12:30 p.m. for a luncheon.
THIS DOCUMENT SUBJECT TO
CONFIDENTIAUTY AGREEMENT.
C T R7- -k H N 0 14°97' E5

il {~ L; V V
- 7 -
List of Participants
JOINP COM6ITTEE ON TOBACCO AND EEALTH
June 20, 1960
/
Tobacco Industry:
Sarl C. Clem.nts
The Tobacco Institute
Philip Grant
.Lorillard Corporation
Frederick P. Haas
Liggett 6 Myers Tobacco Co.
David K. Hardy
Shook, Hardy, Ottp.an
Mitchell & Bacon
Cyril Hotsko
As*rican Tobacco Company
H. HOnry Ramm'
R. J. Reynolds Tobacco Co.
Paul Smith
Philip llorris, Inc.
Addison Y. Yoaman
Brown b Williamson Tobacco Corp.
Tobacco Research Council:
Richard J. BinBi 11.D.
Wayne State University
CTR/AMA-ERP
licE"n Cattell, M.D.
Cornell tlnivorsity
Leon 0. Jacobson, M.D.
University of Chicago
Clarence C. Littl., Sc.D.
CTR
Sheldon Soam.rs, Y.D.
Colmsbia University
/
THIS DOCUMENT SUBJECT To
CONFIDENTIAIITY AGREEMENT.
lr TR nI"t 01"Z' 9'i`,G

N K 'J ~S54 , ' -
~
/
List of Participants--
Joint Committee
on Tobacco and Health
National Institutes of Health:
Francis R. Abinanti, D.V.M., Ph.D.
National Institute of Allergy
and Infectious Diseases
Carl 0. Baker, M.D.
National Cancer Institute
Kenneth g, Endicott, M.D.
National Cancer Institute
Paul gotin, b(.D,
Division of Environmental
Health Sciences
Gardiner C, Mcltillan, M.D.
National Heart Institute
Ian A. 14itchell, M.D.
National Cancer Institute
8
AMA-nF Committee for
Research on Tobacco and Health:
Robert J. Hasterlik, M.D.
University of Chicago
John B. Hickam, M.D.
Indiana University
Paul S. Larson, Ph.D.
Medical College of Virginia
Maurice H. Seevers, M.D.
University of Michigan
Ira Singer, Pk.D.
AMA
Recorders:
Hiss Susan.Kotleba
Mrs. Barbara McClintock
THIS DOCUMENT SUBIECT TO
,COMFIDEHTIAUJY AGREEMENT.
CTR H~`~ 0~.49r`~~~~

^~. '~
H K ~`:i ki ~1Vy`' i l
- 9 -
SU8-COMMTITEE
of the
JOINT COMIPI'PEE ON T OBACCO AND HBALTH
Present
Sub-Comaittee: Drs. Baker, Hickam, Jacobson, Kotir.,
Larson, Sommers and Mitchell
Observers: Drs. Abinanti, Little, McMillan
and Singer
Dr. 3aker called the Sub-Committ.e meeting to order at 11:00 a.m.
The Sub-Committee discussed the possibility of sponsoring a scientific
conference, but felt that such a meeting would not be necessary to
prepare a statement. Dr. Jacobson reiterated his conception of the
purpose of the meetin8: it is recognized that certain areas require
investigationj therefore, the Sub-Committee should concentrate on
outlining specific priorities and estimating the costs of undertaking
the requisit/+ studies as well as encouraging inter-committee communi-
cation. However, it was emphasized that the mission of the Sub-
Coemittee includes aore thrn a liaison function, and that atudies of
tobacco and health should provide an opportunity to investigate broader
problems of disease.
Dr. Baker raised the issue of how to deal with the question of
association betwoen specific diseases and rtmoking. It was decided
that any documnt which may evolve should briefly summarize the findinas
of previous studies to avoid duplication. However, the Department will
attempt to keep this effort separate from its continuing public education
campaign.
In discussing how the Sub-Committeo should proceed# Dr. Jacobson
auaested that each of the three groups prepare its own outline of
the fields that require further research. This would perait the Sub-Committee
to discuss the relative position in terms of priorities, ete. and prepare
a combined statement. It was pointed out that the different emphases
which emerge will effectively identify the saps in existing knowledge.
With regard to the direction, Dr. Larson asked if the report would be
concerned with the production of a safer cisarette. Dr. Baker replied that
this approach would be emphasized in the Task Force's report.
THIS DOCUMENT SUBIECT TO
CONFIDENTIALITY AGREEMENT,
Uk" [IN 014 971B

H
Sub-Committee
JCTH - 10 -
Dr. Jacobson expressed the hope that a virologist would be consulted to
explore the association between respiratory viruses and smoking.
The Sub-Committee agreed to meet again on about November 1 in Washington,
D.C. or New York-with the understanding that it might meet earlier if
the stateaents of the individual organizations are available. At that
time it will discuss thase documents and attempt to prepare a combined
statement which can be submitted for the consideration of the Joint
Committee on Tobacco and Health. Further contacts with the Council for
Tobacco Research SAS and the Ab1A-ERF Committee for Research on Tobacco
and Health will be through Mr. Hoyt or Dr. Hockett# and Dr. Singer
respectively.
The meeting adjourned at noon.
It was subsequently agreed to establish the following schedule:
About October 23 ltach of the three groups composin6
~ the Sub-Committee circulate its
statement to the remaining two groups
About November 15 Meeting of the Sub-Committee to meld
the three statements
About December 10 Meeting of the Joint Committee to
discuss proposed final document
About January 1S, 1969 Submit final document to Secretary, HEW
THIS DOCUMENT SUBJECT TO
CONFIDENTIALITY AGREEMENT,
CTR M~~ 014~i'~~''~~
